Treatment for malaria is provided by hydroxychloroquine, a medication that is both ancient and inexpensive. As a result of reports in the media suggesting that Hydroxychloroquine could be used to protect healthcare workers who were treating COVID-19 patients from infection, the Indian government prohibited the drug’s export during the peak of the epidemic.
US President Donald Trump has threatened to retaliate if New Delhi refuses to allow the export of the antimalarial drug hydroxychloroquine, which is currently prohibited in the country, as part of his personal and political relationship with the country. The warning comes as part of his personal and political relationship with India. As for New Delhi, Trump stated that he would be surprised if the country did not show compassion, owing to the fact that the two countries have a positive relationship.